NovoCure Limited Profile Avatar - Palmy Investing

NovoCure Limited

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and G…

Medical - Instruments & Supplies
JE, Saint Helier [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

NovoCure Limited can't present it's latest revenue by geo. area

Revenue By Geographic Areas

NovoCure Limited can't present it's latest revenue by geo. area

Historical Revenue By Segment

Last 3Y, in mil. USD

NovoCure Limited can't present revenue by segment

Historical Revenue By Geographic Area

Last 3Y, in mil. USD

NovoCure Limited can't present revenue by geo. area

End of NVCR's Analysis
CIK: 1645113 CUSIP: G6674U108 ISIN: JE00BYSS4X48 LEI: - UEI: -
Secondary Listings
NVCR has no secondary listings inside our databases.